Nov 4 2013
Johnson & Johnson and Janssen Pharmaceuticals, Inc. to pay $1.72B to resolve health care fraud allegations against government programs Attorney General Bob Ferguson announced that Washington has joined with other states and the federal government in a global settlement with New Jersey pharmaceutical manufacturer, Johnson & Johnson (J & J) and its subsidiary, Janssen Pharmaceuticals, Inc., to resolve civil allegations of unlawful marketing practices to promote the sales of their atypical antipsychotic drugs, Risperdal and Invega.
Sep 26 2013
AG Ferguson presents $138,721 grant to Seattle Indian Health Board for new chronic pain management program
Check arrives before American Indian Day on Sept. 27 Attorney General Bob Ferguson presented a $138,721 grant to the Seattle Indian Health Board (SIHB) to develop its new Chronic Pain Management Project patient registry. The registry will help SIHB health care providers identify and create individualized service plans for patients with chronic pain and other diagnoses.
Aug 1 2013
Wyeth Pharmaceutical to pay $491M, Washington state will receive $261K Attorney General Bob Ferguson announced today that Washington has joined with other states and the federal government in a $491 million settlement against Wyeth Pharmaceuticals Inc., a pharmaceutical company acquired by Pfizer Inc. in 2009.
Jul 15 2013
The Attorney General’s Office Medicaid Fraud Control Unit (MFCU) filed felony criminal charges against Burnice R. Thompson in Thurston County Superior Court today.
Jul 10 2013
The Attorney General’s Office Medicaid Fraud Control Unit (MFCU) has entered into diversion agreements with two defendants in connection with falsifying timesheets as paid caregivers under the Medicaid program.
Jun 13 2013
The Attorney General’s Office Medicaid Fraud Control Unit (MFCU) has charged an Otis Orchards woman with one count of 1st degree theft and two counts of making a false statement to obtain a Medicaid payment.
May 20 2013
OLYMPIA—Washington has joined with other states and the federal government in a $500 million dollar settlement to resolve civil and criminal allegations against Ranbaxy, a generic pharmaceutical manufacturer based in Gurgaon, India. The company is alleged to have introduced adulterated—or tainted— drugs into interstate commerce, resulting in false or fraudulent claims being submitted to Washington’s Medicaid Program.
May 2 2013
Drug Manufacturer Amgen Agrees To Pay Medicaid Program Nearly $26 Million To Resolve Two False Claims Cases
Attorney General Bob Ferguson announced today Washington has joined a national settlement against the drug manufacturer Amgen, Inc., resolving allegations that Amgen violated certain state false claims acts by reporting inflated pricing data for its prescription drugs Aranesp, Enbrel, Epogen, Neulasta, Neupogen, and Sensipar.
Mar 8 2013
OLYMPIA-- Attorney General Bob Ferguson announced today that Washington has joined with other states and the federal government in a $22.5 million settlement with Par Pharmaceutical Companies, Inc. (“Par”). The states allege Par promoted sales of the drug Megace ES for uses not approved as safe and effective by the Food and Drug Administration (“FDA”) and not covered by the State Medicaid programs.
Feb 27 2013
In a case involving multiple jurisdictions, tracking the accused to Nigeria and Texas and back to Washington, a man charged with committing roughly $100,000 in Medicaid fraud finally pled guilty to 10 counts of First Degree Theft in Thurston County Superior Court today.